An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting
Hesham Elhalawani(The University of Texas MD Anderson Cancer Center), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Roy H. Decker(Yale University), Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Emma B. Holliday(The University of Texas MD Anderson Cancer Center), Timothy A. Lin(The University of Texas MD Anderson Cancer Center), Kenneth Ulin(University of Massachusetts Chan Medical School), Omar Mahmoud(South Essex Partnership University Foundation NHS Trust), Anna Shapiro(SUNY Upstate Medical University), Musaddiq Awan, Jayashree Kalpathy–Cramer(University of Colorado Denver), Paul Okunieff(Unknown), Abhilasha Patel(The University of Texas at San Antonio Health Science Center), Thomas Guerrero(University of California San Diego), Baher Elgohari(The University of Texas MD Anderson Cancer Center), Daniel R. Gomez(Cedars-Sinai Medical Center), Jing Zeng(Fred Hutch Cancer Center), Gary V. Walker(Portland State University), Lisa A. Kachnic(NewYork–Presbyterian Hospital), Roi Dagan(University of Florida), Feng‐Ming Kong(Shenzhen Metro (China)), Abdallah Mohamed(The University of Texas MD Anderson Cancer Center), William E. Jones(The University of Texas Health Science Center at San Antonio), Laurie E. Gaspar(University of Colorado Cancer Center), Charles R. Thomas(Dartmouth–Hitchcock Medical Center), Gregory A. Russo(Jefferson College), Fran Laurie(University of Massachusetts Chan Medical School), Mehee Choi(The University of Texas MD Anderson Cancer Center), F. Spoelstra(Amsterdam University Medical Centers)
Cited by 4
Related Papers
3D Slicer as an image computing platform for the Quantitative Imaging Network
|Magnetic Resonance Imaging|2012|9.1k
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k